Composition for preventing and treating stroke, comprising hla homozygous induced pluripotent stem cell-derived neural precursor cells
AssigneesCha University Industry-Academic Cooperation Foundation, Ips Bio, Inc.
InventorJihwan SONG
Life of this patent
Estimating the term…
Abstract
A pharmaceutical composition for preventing or treating a stroke, the pharmaceutical composition comprising, as an active ingredient, neural precursor cells differentiated from HLA homozygous human induced pluripotent stem cells (hiPSC-NPC), wherein, through the use of a homozygous type, immunorejection may be eliminated and stable therapeutic effects for stroke may be exhibited.
Claims10
A pharmaceutical composition for preventing or treating a stroke, the pharmaceutical composition comprising:
- a neural precursor cell differentiated from an HLA homozygous human induced pluripotent stem cell (hiPSC-NPC) comprising an HLA homozygote as an active ingredient.
A method of producing a neural precursor cell differentiated from a HLA homozygous human induced pluripotent stem cell comprising an HLA homozygote, the method comprising:
- differentiating the HLA homozygous human induced pluripotent stem cell comprising the HLA homozygote into the neural precursor cell.
Dependencies are inferred from the claim text.